DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000MG4CYX7

Real-time Bid/Ask 14:22:43 24/06/2024 BST
0.099 EUR / 0.107 EUR +0.98% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-50.00%
1 month-69.09%
Date Price Change
24/06/24 0.103 +0.98%
21/06/24 0.102 +4.08%
20/06/24 0.098 -5.77%
18/06/24 0.104 +18.18%
17/06/24 0.088 -4.35%

Delayed Quote Börse Stuttgart

Last update June 24, 2024 at 09:48 am

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4CYX
ISINDE000MG4CYX7
Date issued 16/05/2024
Strike 107.5 $
Maturity 20/12/2024 (179 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.35
Lowest since issue 0.076

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
62.48 USD
Average target price
86.09 USD
Spread / Average Target
+37.78%
Consensus